Cargando…
A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats
SIMPLE SUMMARY: We developed and validated a preclinical in vivo hyperthermic intraperitoneal chemotherapy (HIPEC) setup using state-of-the-art techniques in rats, including dedicated treatment planning tools and a computer-aided design to achieve well-controlled homogeneous peritoneal flow. Our fou...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760897/ https://www.ncbi.nlm.nih.gov/pubmed/33255921 http://dx.doi.org/10.3390/cancers12123516 |
Sumario: | SIMPLE SUMMARY: We developed and validated a preclinical in vivo hyperthermic intraperitoneal chemotherapy (HIPEC) setup using state-of-the-art techniques in rats, including dedicated treatment planning tools and a computer-aided design to achieve well-controlled homogeneous peritoneal flow. Our four-inflow construction resulted in more stable and homogeneous thermal distributions than using a one-inflow construction, with lower standard deviations and less thermal losses. Core temperatures were kept stable using occasional tail cooling, and rarely exceeded 39 °C. This validated design can improve accuracy in future in vivo experiments investigating the impact of relevant treatment parameters on the efficacy of different HIPEC protocols such as: drug type, temperature and duration. ABSTRACT: Background: Hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery (CRS) is used for treating peritoneal metastases of various origins. Present HIPEC protocols have rarely been validated for relevant parameters such as optimal agent, duration and perfusate temperature. In vitro experiments are not completely representative of clinical circumstances. Therefore, a good preclinical in vivo HIPEC model is needed in which temperature distributions can be well-controlled and are stable throughout treatments. Methods: We designed a setup able to generate and maintain a homogeneous flow during a 90-min HIPEC procedure using our in-house developed treatment planning tools and computer aided design (CAD) techniques. Twelve rats were treated with heated phosphate-buffered saline (PBS) using two catheter setups (one vs. four- inflows) and extensive thermometry. Simulated and measured thermal distribution and core temperatures were evaluated for the different setups. Results: Overall, the four-inflow resulted in more stable and more homogeneous thermal distributions than the one-inflow, with lower standard deviations (0.79 °C vs. 1.41 °C at the outflow, respectively) and less thermal losses. The average thermal loss was 0.4 °C lower for rats treated with the four-inflow setup. Rat core temperatures were kept stable using occasional tail cooling, and rarely exceeded 39 °C. Conclusion: Increasing the number of inflow catheters from one to four resulted in increased flow and temperature homogeneity and stability. Tail cooling is an adequate technique to prevent rats from overheating during 90-min treatments. This validated design can improve accuracy in future in vivo experiments investigating the impact of relevant parameters on the efficacy of different HIPEC protocols. |
---|